Literature DB >> 16170815

Optimization of the PAXgene blood RNA extraction system for gene expression analysis of clinical samples.

Viengthong Chai1, Aikaterini Vassilakos, Yoon Lee, Jim A Wright, Aiping H Young.   

Abstract

One major problem associated with collecting whole blood from patients for use as a source of RNA in gene expression studies is that the RNA degrades during collection and storage. Preservation of RNA quality is vital in such studies because the stability of the RNA ultimately affects analysis of gene expression. In this study the PAXgene blood collection system was compared with a standard erythrocyte lysis method for isolating RNA from blood samples. The methods were compared in terms of RNA yield, RNA stabilization, and DNA contamination. The study also included the downstream application to RT-PCR analysis for relative mRNA expression levels of the ribonucleotide reductase subunits R1 and R2. The results show that blood collection in conventional collection tubes, and leukocyte isolation by erythrocyte lysis lead to significant degradation of RNA. Our findings confirm the ability of PAXgene to stabilize RNA in whole blood; however, RNA extracted by the PAXgene method contained significant DNA contamination. Given the low basal expression of the target genes analyzed in this study, contaminating DNA could potentially affect accurate interpretation of RT-PCR data. As a result, the PAXgene protocol was optimized to include off-column DNase treatments, which yielded high-quality RNA suitable for gene expression studies. Furthermore, the results suggest that RNA isolation with PAXgene is advantageous compared to traditional extraction methods for RT-PCR analysis of large or different-sized amplicons. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170815      PMCID: PMC6807908          DOI: 10.1002/jcla.20075

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  9 in total

1.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

Authors:  J Winer; C K Jung; I Shackel; P M Williams
Journal:  Anal Biochem       Date:  1999-05-15       Impact factor: 3.365

2.  Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR.

Authors:  L Overbergh; D Valckx; M Waer; C Mathieu
Journal:  Cytokine       Date:  1999-04       Impact factor: 3.861

3.  Stabilization of mRNA expression in whole blood samples.

Authors:  Lynne Rainen; Uwe Oelmueller; Stewart Jurgensen; Ralf Wyrich; Cynthia Ballas; Jim Schram; Chris Herdman; Danute Bankaitis-Davis; Nancy Nicholls; David Trollinger; Victor Tryon
Journal:  Clin Chem       Date:  2002-11       Impact factor: 8.327

4.  Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays.

Authors:  Dzung C Thach; Baochuan Lin; Elizabeth Walter; Rusty Kruzelock; Robb K Rowley; Clark Tibbetts; David A Stenger
Journal:  J Immunol Methods       Date:  2003-12       Impact factor: 2.303

Review 5.  Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.

Authors:  S A Bustin
Journal:  J Mol Endocrinol       Date:  2002-08       Impact factor: 5.098

6.  In-vitro production of TNF-alpha in blood samples.

Authors:  R Freeman; J Wheeler; H Robertson; M L Paes; J Laidler
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

7.  A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood.

Authors:  J Aerts; W Wynendaele; R Paridaens; M R Christiaens; W van den Bogaert; A T van Oosterom; F Vandekerckhove
Journal:  Ann Oncol       Date:  2001-01       Impact factor: 32.976

8.  Ex vivo induction of cytokine mRNA expression in human blood samples.

Authors:  C Härtel; G Bein; M Müller-Steinhardt; H Klüter
Journal:  J Immunol Methods       Date:  2001-03-01       Impact factor: 2.303

9.  Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations.

Authors:  P Riches; R Gooding; B C Millar; A W Rowbottom
Journal:  J Immunol Methods       Date:  1992-08-30       Impact factor: 2.303

  9 in total
  25 in total

1.  Transcriptional Signatures of Sleep Duration Discordance in Monozygotic Twins.

Authors:  N F Watson; D Buchwald; J J Delrow; W A Altemeier; M V Vitiello; A I Pack; M Bamshad; C Noonan; S A Gharib
Journal:  Sleep       Date:  2017-01-01       Impact factor: 5.849

2.  Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa.

Authors:  David R Boulware; David B Meya; Tracy L Bergemann; Darlisha Williams; Irina A Vlasova-St Louis; Josh Rhein; Jack Staddon; Andrew Kambugu; Edward N Janoff; Paul R Bohjanen
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

3.  Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics.

Authors:  T Baas; C R Baskin; D L Diamond; A García-Sastre; H Bielefeldt-Ohmann; T M Tumpey; M J Thomas; V S Carter; T H Teal; N Van Hoeven; S Proll; J M Jacobs; Z R Caldwell; M A Gritsenko; R R Hukkanen; D G Camp; R D Smith; M G Katze
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

4.  Characterization of whole blood gene expression profiles as a sequel to globin mRNA reduction in patients with sickle cell disease.

Authors:  Nalini Raghavachari; Xiuli Xu; Peter J Munson; Mark T Gladwin
Journal:  PLoS One       Date:  2009-08-03       Impact factor: 3.240

5.  Stabilizing the code-methods to preserve RNA prove their worth.

Authors:  Marc A Williams
Journal:  Biomark Insights       Date:  2010-12-01

6.  Gene expression profiling in whole blood of patients with coronary artery disease.

Authors:  Chiara Taurino; William H Miller; Martin W McBride; John D McClure; Raya Khanin; María U Moreno; Jane A Dymott; Christian Delles; Anna F Dominiczak
Journal:  Clin Sci (Lond)       Date:  2010-07-09       Impact factor: 6.124

7.  Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks.

Authors:  Daniel Gilbert Weber; Swaantje Casjens; Peter Rozynek; Martin Lehnert; Sandra Zilch-Schöneweis; Oleksandr Bryk; Dirk Taeger; Maria Gomolka; Michaela Kreuzer; Heinz Otten; Beate Pesch; Georg Johnen; Thomas Brüning
Journal:  Biomark Insights       Date:  2010-09-22

Review 8.  Overview of microarray analysis of gene expression and its applications to cervical cancer investigation.

Authors:  Angel Chao; Tzu-Hao Wang; Chyong-Huey Lai
Journal:  Taiwan J Obstet Gynecol       Date:  2007-12       Impact factor: 1.705

9.  A practical platform for blood biomarker study by using global gene expression profiling of peripheral whole blood.

Authors:  Ze Tian; Nathan Palmer; Patrick Schmid; Hui Yao; Michal Galdzicki; Bonnie Berger; Erxi Wu; Isaac S Kohane
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

10.  Effects of Exercise on Low Density Lipoprotein Receptor Related Protein 5 Gene Expression in Patients With Postmenopausal Osteoporosis.

Authors:  Gamze Kiliç; Didem Dayangaç Erden; Özlem Erol; Erkan Kiliç; Murat Kara; Hayat Erdem Yurter; Ayşen Akinci
Journal:  Arch Rheumatol       Date:  2016-04-25       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.